Search results for Iratumumab
Iratumumab, Abbexa, abx831134
Iratumumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF8/CD30, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Immunoglobulin G1, anti-(human CD30 (antigen)) (human monoclonal MDX-060 heavy chain), disulfide with human monoclonal MDX-060 light chain, dimer. Molecular weight is approximately 170, 000 daltons. In phase I/II clinical trials for treatment of CD30+ lymphomas.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Iratumumab Biosimilar - Research Grade, ichor.bio, ICH5085
Detects human CD30
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Iratumumab (HB038026), abinScience, HB038026
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.